Hahnfeldt P

No ORCID on file · 1 paper in corpus · active 2002
2002
The Journal of clinical investigation ·doi:10.1172/jci15634

Several drugs approved for a variety of indications have been shown to exhibit antiangiogenic effects. Our study focuses on the PPARgamma ligand rosiglitazone, a compound widely used in the treatment of type 2 diabetes. We demonstrate, for …